3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
23
Carcinoma, Non-Small-Cell Lung
16
Ovarian Neoplasms
13
Fallopian Tube Neoplasms
12
Carcinoma, Hepatocellular
10
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Melanoma
7
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Triple Negative Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Mycosis Fungoides
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Glioblastoma
4
Thyroid Neoplasms
3
Sezary Syndrome
3
Nasopharyngeal Carcinoma
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, T-Cell
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Brenner Tumor
3
Brain Neoplasms
3
Interventions
pembrolizumab
5
Nivolumab
3
durvalumab
2
tremelimumab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
avelumab
1
atezolizumab
1
Therapeutics
1
Temozolomide
1
Surgical Procedures, Operative
1
Neoadjuvant Therapy
1
Ipilimumab
1
Injections
1
Docetaxel
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Bevacizumab
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Microsatellite Instability
×
Immunoglobulin G
×
1 year
×
Clear all
No trials found.